Simon Edwards-Parton

Publications (2)27.28 Total impact

• Article: The Global Cell Therapy Industry Continues to Rise during the Second and Third Quarters of 2012.

  Chris Mason, Mark J McCall, Emily J Culme-Seymour, Shalini Suthasan, Simon Edwards-Parton, Gregory A Bonfiglio, Brock C Reeve
  [show abstract] [hide abstract]
  ABSTRACT: During Q2-Q3 2012, the cell therapy industry benefited from a number of positive external influences including advantageous changes to future FDA regulation, but stock market activity was highly mixed. The FDA approved two more products and an appreciable number of public-company-sponsored clinical trials are progressing through phases 1-3.
  Cell stem cell 12/2012; 11(6):735-9. · 23.56 Impact Factor
• Article: A decade of cell therapy clinical trials (2000-2010).

  Emily J Culme-Seymour, Natasha L Davie, David A Brindley, Simon Edwards-Parton, Chris Mason
  Regenerative Medicine 07/2012; 7(4):455-62. · 3.72 Impact Factor